Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-25 @ 9:31 PM
Study NCT ID:
NCT00138151
Status:
TERMINATED
Last Update Posted:
2013-11-20
First Post:
2005-08-29
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer
Sponsor:
University of Medicine and Dentistry of New Jersey
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-03
Start Date Type:
None
Primary Completion Date:
2010-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-11
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-29
First Submit QC Date:
None
Study First Post Date:
2005-08-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-09-17
Results First Submit QC Date:
None
Results First Post Date:
2013-11-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-09-17
Last Update Post Date:
2013-11-20
Last Update Post Date Type:
ESTIMATED